Decreasing delivery room CPAP-associated pneumothorax at ≥35-week gestational age

J Perinatol. 2022 Jun;42(6):761-768. doi: 10.1038/s41372-022-01334-4. Epub 2022 Feb 16.

Abstract

Objective: We previously reported an increase in pneumothorax after implementing delivery room (DR) continuous positive airway pressure (CPAP) for labored breathing or persistent cyanosis in ≥35-week gestational age (GA) neonates unexposed to DR-positive pressure ventilation (DR-PPV). We hypothesized that pneumothorax would decrease after de-implementing DR-CPAP in those unexposed to DR-PPV or DR-O2 supplementation (DR-PPV/O2).

Study design: In a retrospective cohort excluding DR-PPV the primary outcome was DR-CPAP-related pneumothorax (1st chest radiogram, 1st day of life). In a subgroup treated by the resuscitation team and admitted to the NICU, the primary outcome was DR-CPAP-associated pneumothorax (1st radiogram, no prior PPV) without DR-PPV/O2.

Results: In the full cohort, occurrence of DR-CPAP-related pneumothorax decreased after the intervention (11.0% vs 6.0%, P < 0.001). In the subgroup, occurrence of DR-CPAP-associated pneumothorax decreased after the intervention (1.4% vs. 0.06%, P < 0.001).

Conclusion: The occurrence of CPAP-associated pneumothorax decreased after avoiding DR-CPAP in ≥35-week GA neonates without DR-PPV/O2.

MeSH terms

  • Continuous Positive Airway Pressure / adverse effects
  • Delivery Rooms
  • Female
  • Gestational Age
  • Humans
  • Infant, Newborn
  • Pneumothorax* / etiology
  • Pregnancy
  • Respiratory Distress Syndrome, Newborn* / therapy
  • Retrospective Studies